Scancell founder says the company is ready to commercialise novel medicines to counteract cancer. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksOrogen Gold Regulatory News (ORE)

  • There is currently no data for ORE

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

EPT Disclosure

27 Feb 2009 12:47

RNS Number : 0299O
Liberum Capital Limited
27 February 2009
 

** Please note that a number of disclosures have been incorrectly reported. The revised disclosures can be found in the table below. **

DEALINGS BY CONNECTED EXEMPT PRINCIPAL TRADERS 

WITH RECOGNISED INTERMEDIARY STATUS

DEALING IN A CLIENT-SERVING CAPACITY

(Rule 38.5(a) of the Takeover Code)

1. KEY INFORMATION

Name of exempt principal trader

Liberum Capital Limited 

Company dealt in

Aricom Plc.

Class of relevant security to which the dealings being disclosed relate (Note 1)

Ordinary Shares 

Date of dealing

26th    February 2009

2. DEALINGS (Note 2)

(a) Purchases and sales

Total number of securities purchased

Highest price paid (Note 3)

Lowest price paid (Note 3)

Nil

Nil

Nil

Total number of securities sold

Highest price received (Note 3)

Lowest price received (Note 3)

70,000

0.29

0.29

(b) Derivatives transactions (other than options)

Product name, 

e.g. CFD

Long/short (Note 4)

Number of securities (Note 5)

Price per unit (Note 3)

N/A

N/A

N/A

N/A

(c) Options transactions in respect of existing securities

(i) Writing, selling, purchasing or varying

Product name,

e.g. call option

Writing, selling, purchasing, varying etc.

Number of securities to which the option relates (Note 5)

Exercise

price 

Type, e.g. American, European etc.

Expiry 

date

Option money

paid/received per unit (Note 3)

N/A

N/A

N/A

N/A

N/A

N/A

N/A

(ii) Exercising

Product name, e.g. call option

Number of securities 

Exercise price per unit (Note 3)

N/A

N/A

N/A

3. OTHER INFORMATION

Agreements, arrangements or understandings relating to options or derivatives

Full details of any agreement, arrangement or understanding between the person disclosing and any other person relating to the voting rights of any relevant securities under any option referred to on this form or relating to the voting rights or future acquisition or disposal of any relevant securities to which any derivative referred to on this form is referenced. If none, this should be stated.

NONE

Date of disclosure

27th  February 2009

Contact name

Carl Chambers 

Telephone number

020 7100 2034

Name of offeree/offeror with which connected

Peter Hambro Plc

Nature of connection (Note 6)

Advisor

Notes

The Notes on Form 38.5(a) can be viewed on the Takeover Panel's website at www.thetakeoverpanel.org.uk

  

Date 

Total Number of securities purchased

Total Number of securities sold

02/02/09

691,732

888,191

04/02/09

2,691,517

2,638,480

05/02/09

4,095,533

4,585,130

06/02/09

2,434,339

2,013,240

09/02/09

1,322,350

1,301,424

10/02/09

172,248

667,818

13/02/09

2,416,854

2,464,337

17/02/09

387,211

302,979

Items in bold reflect the revised figure.

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
EMMSEIFEWSUSELE
Date   Source Headline
16th Oct 20084:43 pmRNSSecond Price Monitoring Extn
16th Oct 20084:41 pmRNSPrice Monitoring Extension
9th Oct 200811:45 amRNSDirector/PDMR Shareholding
9th Oct 200811:45 amRNSDirector/PDMR Shareholding
9th Oct 200811:45 amRNSDirector/PDMR Shareholding
9th Oct 20087:00 amRNSLong Term Incentive Plan Continuation
8th Oct 20087:00 amRNSCompletion of Feasibility Study
30th Sep 200810:46 amRNSExercise of options for extensions
29th Sep 200810:50 amRNSHolding(s) in Company
26th Sep 200812:06 pmRNSRe announcement of feasibility study results
25th Sep 200811:16 amRNSHolding(s) in Company
24th Sep 20082:21 pmRNSHolding(s) in Company
19th Sep 20084:42 pmRNSSecond Price Monitoring Extn
19th Sep 20084:39 pmRNSPrice Monitoring Extension
17th Sep 20089:07 amRNSHolding(s) in Company
29th Aug 20087:00 amRNSJoint Venture with Chinalco
26th Aug 20081:32 pmRNSHolding(s) in Company
20th Aug 200812:49 pmRNSHolding(s) in Company
6th Aug 20087:15 amRNSInterim Results
6th Aug 20087:00 amRNSNon-Executive Board Appointme
28th Jul 200810:56 amRNSNotice of Results
3rd Jul 200812:32 pmRNSHolding(s) in Company
24th Jun 20081:10 pmRNSDirector/PDMR Shareholding
19th Jun 20087:00 amRNSFirst sales from Kuranakh dep
6th Jun 200811:12 amRNSHolding(s) in Company
3rd Jun 20083:46 pmRNSHolding(s) in Company
27th May 20087:00 amRNSAppointment of Financial Advi
20th May 20084:40 pmRNSHolding(s) in Company
8th May 20087:01 amRNSInterim Management Statement
15th Apr 20083:08 pmRNSResult of AGM
31st Mar 20085:28 pmRNSHolding(s) in Company
25th Mar 20087:01 amRNSAcquisitions
7th Mar 200810:45 amRNSAnnual Information Update
7th Mar 20087:00 amRNSNotice of AGM
4th Mar 20084:08 pmRNSHolding(s) in Company
27th Feb 20084:20 pmRNSExercise of Share Options
21st Feb 20087:00 amRNSFinal Results
20th Feb 20085:45 pmRNSHolding(s) in Company
15th Feb 200811:45 amRNSResult of EGM
12th Feb 200810:54 amRNSNotice of Results
30th Jan 20084:21 pmRNSTotal Voting Rights
29th Jan 20087:01 amRNSNew Head of IR
21st Jan 20082:21 pmRNSHolding(s) in Company
17th Jan 20083:38 pmRNSPublication of circular & EGM
15th Jan 20085:48 pmRNSHolding(s) in Company
10th Jan 20087:01 amRNSTitanium Feasibilty Study
21st Dec 20077:01 amRNSTotal Voting Rights
13th Dec 200711:19 amRNSResult of Vendor Placing
13th Dec 20077:02 amRNSPlacing
13th Dec 20077:01 amRNSGarinskoye Interest Increase

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.